COVID-19 Booster Shots with closeup of a gloved hand holding a vaccine vial

COVID-19 Vaccine Booster Shots

FDA has amended the Emergency Use Authorization for the Pfizer-BioNTech COVID-19 Vaccine to allow for use of a single booster dose, to be administered at least six months after completion of the primary series in people 65 and older, 18 and older who have underlying medical conditions, and people 18 and older who live and work in high-risk settings.

Read More ›
Woman in blue scrubs and a stethoscope around her neck with a white horse on one side, and a standing man in a white doctor's coat with a face mask on feeling the neck of another seated man with a face mask on in a doctor's office. With text, Why You Should NOT Use Ivermectin To Treat or Prevent COVID-19

Why You Should Not Use Ivermectin to Treat or Prevent COVID-19

The FDA has not authorized or approved ivermectin for use in preventing or treating COVID-19 in humans or animals and currently available data do not show ivermectin is effective against COVID-19. Never use medications intended for animals on yourself or other people. Animal ivermectin products are very different from those approved for humans. Use of animal ivermectin for the prevention or treatment of COVID-19 in humans is dangerous.

Read More ›
Changes to SSI for Recipients & Applicants: Most types of pandemic-related financial assistance won’t count against SSI eligibility or benefit amount

Important Change for SSI Recipients and Applicants

The Social Security Administration (SSA) has recently changed their rules about what types of financial assistance can affect an individual’s Supplemental Security Income (SSI) eligibility or their monthly SSI payment amount. Due to the COVID-19 pandemic, SSA no longer counts most types of pandemic-related financial assistance against eligibility or payment amount. This includes Economic Impact Payments (EIP), State Stimulus Payments, and Unemployment Assistance, and more.

Read More ›
FDA Approves Pfizer's COVID-19 Vaccine, with photograph of a vial of COVID-19 vaccine held in a hand with blue vinyl gloves

FDA Approves Pfizer’s COVID-19 Vaccine

The FDA approved the Pfizer-BioNTech COVID-19 Vaccine for the prevention of COVID-19 disease in individuals 16 years of age and older. The vaccine also continues to be available under emergency use authorization (EUA), including for individuals 12 through 15 years of age and for the administration of a third dose in certain immunocompromised individuals. The vaccine will now be marketed as Comirnaty.

Read More ›
Masks Required in Public with illustration of a face mask

New Mexico Mask Mandate Re-Instated

The most recent New Mexico Public Health Order states that, as of August 20, 2021 everyone in New Mexico over the age of 2, regardless of vaccination status, is required to wear a mask or cloth face covering when in public except when drinking, eating, or under medical instruction.

Read More ›
Illustration of a syringe with text, CDC Approves 3rd Dose of COVID-19 Vaccine for Immunocompromised People

COVID-19 Vaccines for Immunocompromised People

CDC now recommends that people whose immune systems are compromised moderately to severely should receive an additional dose of mRNA COVID-19 vaccine after the initial 2 doses. Widespread vaccination is a critical tool to help stop the pandemic.

Read More ›